Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Filter Contract Award

20 Dec 2011 09:45

RNS Number : 3098U
Avon Rubber PLC
20 December 2011
 



20 December 2011

FILTER CONTRACT AWARD

Avon is pleased to announce that it has received a 5 year contract from the Department of Defense (DoD) for the supply of spare filters for its M50 respirator. Like previous contracts for spare filters, the contract is an Indefinite Delivery Indefinite Quantity ("IDIQ") contract and has a maximum order quantity of 2.4m filter pairs per year and 12m filter pairs over the contract term. The contract also allows the DoD to extend the term by 2 further option years, potentially extending the duration to 7 years. An initial order has been placed by the DoD with a value of $2.5m for immediate delivery.

This new contract is in addition to the existing sole source $38m, 3 year IDIQ contract announced in August. Avon has also received a further delivery order against this contact with a value of $6.1m for delivery by 1 April 2012.

As expected, the DoD has chosen to dual source the procurement of spare filters and another source has also been selected for a 5 year contract award. The Directors believe that it will take up to 2 years for a comparable product to be developed and approved, after which orders for filters for the M50 mask will be competitively bid. The supply of filters with M50 mask systems will remain sole sourced to Avon.

Commenting on the news, Peter Slabbert, Chief Executive said: "We are delighted to have been awarded this new contract which confirms Avon's position as a supplier of consumable filters to the DoD for a further 5 to 7 years. The procurement of the filter for the M50 mask from another supplier was expected and we believe that our state of the art manufacturing capability, our existing technology advantage and the continuation of the sole source window for up to another 2 years will allow Avon to retain its competitive advantage. We are also committed to widening our capability and product range in the area of filtration to enable us to continue to grow this repeat revenue stream."

For further enquiries, please contact:

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896 870

Andrew Lewis, Group Finance Director

01225 896 830

Fiona Stewart, Corporate Communications Executive

01225 896 871

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

 

NOTES TO EDITORS: Avon Rubber p.l.c. is a world leader in the design, test and manufacture of advanced Chemical, Biological, Radiological and Nuclear (CBRN) respiratory protection solutions to the worlds military, law enforcement, first responder, emergency services, fire and industrial markets. Avon has a unique capability in CBRN protection based on a range of advanced CBRN technologies in respirator design, filtration and compressed air breathing apparatus. This enables Avon to develop specialised solutions that take full account of user requirements. Avon also owns a world leading dairy business manufacturing liners and tubing for the automated milking process. For further information please visit the Group's website www.avon-rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGCBDDRDDBGBG
Date   Source Headline
6th Nov 20142:21 pmRNSDirector/PDMR Shareholding
8th Oct 20144:06 pmRNSDirector/PDMR Shareholding
3rd Oct 20147:00 amRNSPre close trading update
16th Sep 20146:08 pmRNSHolding(s) in Company
8th Sep 201412:29 pmRNSDirector/PDMR Shareholding
7th Aug 20145:56 pmRNSDirector/PDMR Shareholding
6th Aug 20147:00 amRNSInterim Management Statement
14th Jul 20142:38 pmRNSHolding(s) in Company
9th Jul 20149:30 amRNSDirector/PDMR Shareholding
16th Jun 20145:03 pmRNSHolding(s) in Company
6th Jun 201412:33 pmRNSDirector/PDMR Shareholding
6th Jun 20147:00 amRNSUS $33m order for US DOD
7th May 20144:01 pmRNSDirector/PDMR Shareholding
7th May 20148:47 amRNSHolding(s) in Company
30th Apr 20147:00 amRNSHalf Yearly Report
15th Apr 20141:46 pmRNSHolding(s) in Company
8th Apr 20149:58 amRNSDirector/PDMR Shareholding
1st Apr 20149:13 amRNSHolding(s) in Company
28th Mar 20147:01 amRNSPre close trading update
10th Mar 201412:27 pmRNSHolding(s) in Company
6th Mar 20149:38 amRNSDirector/PDMR Shareholding
6th Mar 20147:00 amRNSUS facility consolidation
17th Feb 20144:58 pmRNSHolding(s) in Company
13th Feb 20145:21 pmRNSHolding(s) in Company
7th Feb 201411:39 amRNSDirector/PDMR Shareholding
6th Feb 20142:10 pmRNSResult of AGM
6th Feb 20147:00 amRNSInterim Management Statement
27th Jan 20148:51 amRNSHolding(s) in Company
14th Jan 20144:30 pmRNSHolding(s) in Company
14th Jan 20144:02 pmRNSDirector/PDMR Shareholding
9th Jan 201411:25 amRNSHolding(s) in Company
7th Jan 20145:14 pmRNSDirector/PDMR Shareholding
30th Dec 20137:00 amRNSHolding(s) in Company
30th Dec 20137:00 amRNSHolding(s) in Company
16th Dec 20139:35 amRNSHolding(s) in Company
11th Dec 201312:44 pmRNSAnnual Financial Report
5th Dec 20134:34 pmRNSDirector/PDMR Shareholding
5th Dec 20133:51 pmRNSDirector/PDMR Shareholding
29th Nov 20133:02 pmRNSDirector/PDMR Shareholding
29th Nov 201311:29 amRNSTotal Voting Rights
25th Nov 201311:15 amRNSIssue of Equity
21st Nov 20132:41 pmRNSDirector/PDMR Shareholding
20th Nov 20137:00 amRNSFinal Results
6th Nov 20134:50 pmRNSDirector/PDMR Shareholding
30th Oct 20133:17 pmRNSHolding(s) in Company
25th Oct 20137:00 amRNSContract Awards
17th Oct 20139:30 amRNSHolding(s) in Company
8th Oct 20135:49 pmRNSDirector/PDMR Shareholding
30th Sep 20137:00 amRNSPre close Trading Update
9th Sep 20139:21 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.